SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen
BIIB 177.08+0.4%Dec 26 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael H. Dragon who wrote (44)10/11/1996 6:06:00 AM
From: David D. Long   of 1686
 
Thanks, Mike. How much was from Avonex? Anybody know? I'm a little confused over how much of that $1.21 was extraodinary, one-time stuff, and how much was from sources that'll continue to contribute to future quarters' earnings. For the dummies among us, it would be really neat to see a simple-minded breakdown of exactly how much of that buck-twenty-one was from the legal settlement, how much was from Avonex, how much was from Intron, and whatever. Also, I'd love to know how many Avonex prescriptions are out there now, and about how many new ones are coming in each week. And because I'm really hard to please, I'd also like to know what a year's worth of Avonex costs to manufacture. Regards - Dave Long
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext